Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease

IMPORTANCE: A reliable method of detecting Alzheimer disease (AD) in its prodromal state is needed for patient stratification in clinical trials or for personalizing existing or potential upcoming therapies. Current cerebrospinal fluid (CSF)– or imaging-based single biomarkers for AD offer reliable...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Neurol
Main Authors: Lehallier, Benoit, Essioux, Laurent, Gayan, Javier, Alexandridis, Roxana, Nikolcheva, Tania, Wyss-Coray, Tony, Britschgi, Markus
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214993/
https://ncbi.nlm.nih.gov/pubmed/26659895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2015.3135
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki